All I'm saying is Novartis looked under the hood and walked away.
Maybe all they saw was the Covid ARDS application. But why wouldn't Si try courting them with all MSB's drug candidates while they were sniffing around?
Seems odd to me.
Don't forget, the FDA has also rejected MSB twice, and they have all the data. Would be nice having some transparency. Guess we will see once Si has another crack at not performing the recommended trials.
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-431
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.83%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.10 | $1.03 | $4.925M | 4.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7260 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 67541 | 7 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |